Who has invested in Surface Oncology?

Catalio Capital Management, Third Rock Ventures, Novo Holdings are named among the investors backing Surface Oncology.

Surface Oncology Funding: $150M Raised, Series A (2024)

Surface Oncology funding overview

Surface Oncology is based in Cambridge, Massachusetts. Surface Oncology has raised $150M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in March 2024. The round record for Surface Oncology runs through 2024; nothing later has been disclosed. Investors on record include Catalio Capital Management, Third Rock Ventures, Novo Holdings. 3 distinct backers are named across the disclosed rounds.

Surface Oncology at a glance

Total raised: $150M
Latest round: Series A
Latest round date: March 2024
Headquarters: Cambridge, Massachusetts
Notable investors: Catalio Capital Management, Third Rock Ventures, Novo Holdings

Frequently asked about Surface Oncology funding

How much has Surface Oncology raised?: Surface Oncology has raised $150M in total disclosed funding across the rounds on record.
Who has invested in Surface Oncology?: Catalio Capital Management, Third Rock Ventures, Novo Holdings are named among the investors backing Surface Oncology.
What was the latest Surface Oncology funding round?: The most recent disclosed round is a Series A, announced in March 2024.
Where is Surface Oncology based?: Surface Oncology is based in Cambridge, Massachusetts.
When did Surface Oncology last raise?: The last disclosed Surface Oncology round closed in March 2024 at Series A.

Every Surface Oncology figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.

Surface Oncology Funding: $150M Raised, Series A (2024)

Surface Oncology funding overview

Surface Oncology at a glance

Frequently asked about Surface Oncology funding

Companies related to Surface Oncology (36)

Browse related funding lists (8)